Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review

  • ID: 4284899
  • SWOT Analysis
  • 42 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Ascendis Pharma A/S
  • Genmab A/S
  • NeuroSearch A/S
  • MORE
Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company that develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. The company develops its products using poxvirus-based technology platforms including vaccinia-fowlpox (VF)-TRICOM and modified vaccinia ankara - bavarian nordic (MVA-BN). Its pipeline products are intended for the treatment of smallpox, prostate cancer, bladder cancer, solid tumors, chronic HPV infection, marburg and ebola infections, and others. Bavarian Nordic has collaboration with US government and various institutes, to develop its product candidates for the treatment of cancer and infectious diseases. It has a presence in the US, Denmark and Germany. Bavarian Nordic is headquartered in Kvistgaard, Denmark.

Bavarian Nordic AS Key Recent Developments

May 10,2017: Bavarian Nordic Announces Appointment of Dr. Tommi Kainu as Chief Business Officer
May 04,2017: Bavarian Nordic Announces Interim Results for the First Three Months of 2017
Mar 15,2017: Bavarian Nordic Announces Annual Report 2016
Jan 17,2017: Henrik Birk Appointed Chief Operating Officer of Bavarian Nordic
Nov 09,2016: Bavarian Nordic Announces Interim Results for the First Nine Months of 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ascendis Pharma A/S
  • Genmab A/S
  • NeuroSearch A/S
  • MORE
Section 1 - About the Company
  • Bavarian Nordic A/S - Key Facts
  • Bavarian Nordic A/S - Key Employees
  • Bavarian Nordic A/S - Key Employee Biographies
  • Bavarian Nordic A/S - Major Products and Services
  • Bavarian Nordic A/S - History
  • Bavarian Nordic A/S - Company Statement
  • Bavarian Nordic A/S - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Bavarian Nordic A/S - Business Description
  • Bavarian Nordic A/S - SWOT Analysis
  • SWOT Analysis - Overview
  • Bavarian Nordic A/S - Strengths
  • Bavarian Nordic A/S - Weaknesses
  • Bavarian Nordic A/S - Opportunities
  • Bavarian Nordic A/S - Threats
  • Bavarian Nordic A/S - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Bavarian Nordic A/S, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 10, 2017: Bavarian Nordic Announces Appointment of Dr. Tommi Kainu as Chief Business Officer
  • May 04, 2017: Bavarian Nordic Announces Interim Results for the First Three Months of 2017
  • Mar 15, 2017: Bavarian Nordic Announces Annual Report 2016
  • Jan 17, 2017: Henrik Birk Appointed Chief Operating Officer of Bavarian Nordic
  • Nov 09, 2016: Bavarian Nordic Announces Interim Results for the First Nine Months of 2016
  • Aug 17, 2016: Bavarian Nordic Announces First Half 2016 Results
  • May 13, 2016: Bavarian Nordic Announces Interim Results for the First Three Months of 2016
  • Mar 07, 2016: Bavarian Nordic Announces Annual Report 2015
  • Feb 18, 2016: Edison Issues ADR Update on Bavarian Nordic
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Bavarian Nordic A/S, Key Facts
  • Bavarian Nordic A/S, Key Employees
  • Bavarian Nordic A/S, Key Employee Biographies
  • Bavarian Nordic A/S, Major Products and Services
  • Bavarian Nordic A/S, History
  • Bavarian Nordic A/S, Other Locations
  • Bavarian Nordic A/S, Subsidiaries
  • Bavarian Nordic A/S, Key Competitors
  • Bavarian Nordic A/S, Ratios based on current share price
  • Bavarian Nordic A/S, Annual Ratios
  • Bavarian Nordic A/S, Annual Ratios (Cont...1)
  • Bavarian Nordic A/S, Annual Ratios (Cont...2)
  • Bavarian Nordic A/S, Interim Ratios
  • Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Bavarian Nordic A/S, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Bavarian Nordic A/S, Performance Chart (2012 - 2016)
  • Bavarian Nordic A/S, Ratio Charts
  • Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd
  • NeuroSearch A/S
  • Medical Prognosis Institute A/S
  • Genmab A/S
  • Ascendis Pharma A/S
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll